- Truist Securities analyst Bill Chappell reiterated a Buy rating on the shares of Olaplex Holdings, Inc. OLPX with a price target of $15.
- The analyst's key takeaways from meetings with management include the following: the brand remains strong with a solid performance from recent dry shampoo launch despite negative headlines and a better understanding of plans to step up marketing and partner engagement in 2023.
- A lawsuit representing 70 women was filed against the company on February 9, claiming that OLPX's products caused hair loss.
- The analyst has found dozens of testimonials from stylists and consumers online refuting the accusations and singing the praises of the product.
- The analyst believes the lawsuit is not fatal and will not create a long-term impairment of the brand.
- Beyond the fact that dry shampoo is a new segment for the company, which could become a meaningful revenue stream, the analyst also views it as a testament to the brand.
- If there were prevalent concerns about the safety of the products, the analyst would have expected it to impact new product launches.
- Management clearly acknowledged that the suit/headlines would impact the business in the near term.
- The analyst believes the guidance and the current stock price more than factor in that impact.
- The analyst believes the shares are one of the most compelling from a risk/reward standpoint in 2023 based on the solid margins/profitability, patented technology, and highly loyal existing base.
- Price Action: OLPX shares are trading higher by 1.80% at $3.94 on the last check Monday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in